Fidelity Investments
SPRB

Fidelity Investments’s Spruce Biosciences SPRB Stock Holding History

Fidelity Investments’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$81 – 5684
2024
Q1 		$81 Buy
+1
New +$254 ﹤0.01% 4991
2023
Q4 		– Hold
0
– -$82 – 5691
2023
Q3 		– Hold
0
– – – 4881
2023
Q2 		– Sell
-1
Closed -$111 – 5626
2023
Q1 		$111 Buy
+1
New +$186 ﹤0.01% 4892
2022
Q4 		– Sell
-6
Closed -$1K – 5623
2022
Q3 		$1K Hold
6
– – ﹤0.01% 4762
2022
Q2 		$1K Sell
6
-87
-94% -$11.1K ﹤0.01% 4826
2022
Q1 		$14K Sell
93
-1,434
-94% -$267K ﹤0.01% 4140
2021
Q4 		$511K Sell
1,527
-11,160
-88% -$3.32M ﹤0.01% 2795
2021
Q3 		$5.72M Sell
12,687
-3,122
-20% -$1.96M ﹤0.01% 2321
2021
Q2 		$13.3M Sell
15,809
-126
-0.8% -$134K ﹤0.01% 2001
2021
Q1 		$19.8M Buy
15,935
+11
+0.1% +$16.9K ﹤0.01% 1810
2020
Q4 		$29M Buy
+15,924
New +$26.4M ﹤0.01% 1546

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Fidelity Investments's SPRB Position: Q2 2024 in Review

Fidelity Investments sold out of Spruce Biosciences (SPRB) in Q2 2024, closing a stake of 1 share — an estimated $81 sold.

Fidelity Investments first reported a position in SPRB in Q4 2020 and held it in 10 quarters. The position peaked at $29M in Q4 2020. 37 funds tracked by Wall St. Rank hold SPRB as of Q2 2024.

  • Fidelity Investments reported no remaining Spruce Biosciences position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 1 Spruce Biosciences share in Q2 2024, an estimated $81.
  • Fidelity Investments first reported a position in Spruce Biosciences in Q4 2020 and held it in 10 quarters.
  • Fidelity Investments's Spruce Biosciences position peaked at $29M in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.